Gyre Therapeutics (GYRE) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 1,303.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,303.98% |
| Dec 31, 2025 | -113.29% |
| Sep 30, 2025 | 280.64% |
| Jun 30, 2025 | 126.95% |
| Mar 31, 2025 | -109.46% |
| Dec 31, 2024 | -359.94% |
| Sep 30, 2024 | -81.58% |
| Jun 30, 2024 | -437.99% |
| Mar 31, 2024 | -69.42% |
| Dec 31, 2023 | -97.55% |
| Sep 30, 2023 | 177.06% |
| Jun 30, 2023 | 116.72% |
| Mar 31, 2023 | 171.99% |
| Dec 31, 2022 | 339.30% |
| Sep 30, 2022 | 67.06% |
| Jun 30, 2022 | 38.91% |
| Mar 31, 2022 | 50.53% |
| Dec 31, 2021 | 20.07% |
| Sep 30, 2021 | -67.33% |
| Jun 30, 2021 | -32.81% |
| Mar 31, 2021 | -406.68% |
| Dec 31, 2020 | -173.42% |
| Sep 30, 2020 | -45.07% |
| Jun 30, 2020 | -31.58% |
| Mar 31, 2020 | 67.90% |
| Dec 31, 2019 | 11.95% |
| Sep 30, 2019 | -29.61% |
| Jun 30, 2019 | -55.27% |
| Mar 31, 2019 | -182.24% |
| Dec 31, 2018 | -44.96% |
| Sep 30, 2018 | -42.46% |
| Jun 30, 2018 | -68.47% |
| Mar 31, 2018 | -23.52% |
| Dec 31, 2017 | -24.28% |
| Sep 30, 2017 | 3.94% |
| Jun 30, 2017 | -13.54% |
| Mar 31, 2017 | 11.13% |
| Dec 31, 2016 | 2.69% |
| Sep 30, 2016 | 46.71% |
| Jun 30, 2016 | -183.61% |
| Mar 31, 2016 | -62.18% |
| Dec 31, 2015 | -154.49% |
| Sep 30, 2015 | -149.56% |
| Jun 30, 2015 | 84.66% |
| Mar 31, 2015 | 79.93% |
| Dec 31, 2014 | -108.87% |
| Sep 30, 2014 | 300.11% |
| Jun 30, 2014 | 14.60% |
| Mar 31, 2014 | -58.10% |
| Dec 31, 2013 | 296.85% |
| Sep 30, 2013 | 6.68% |
| Jun 30, 2013 | 40.11% |
| Mar 31, 2013 | 62.36% |
| Dec 31, 2012 | 43.24% |
| Sep 30, 2012 | 42.99% |
| Jun 30, 2012 | 25.77% |
| Mar 31, 2012 | -10.17% |
| Dec 31, 2011 | -19.95% |
| Sep 30, 2011 | -6.19% |